Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Plasmodium Immunotherapy for Advanced Cancers
NCT03375983Phase 2Recruiting
- Sponsor
- CAS Lamvac Biotech Co., Ltd.
- Start
- Nov 2017
- Primary completion
- Mar 2023
- Countries
- 1
01
Overview
A Phase 2 trial of plasmodium vivax in solid tumor (advanced stage), sponsored by CAS Lamvac Biotech Co., Ltd.. Started Nov 2017; status: recruiting.
02
Drugs
plasmodium vivax
03
Conditions
solid tumor (advanced stage)
Beyond the preview
Go deeper on NCT03375983.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03375983.